Open AccessEXPERIENCE WITH THE CARBAMYLATED MONOMERIC ALLERGOID LAIS ® FOR SUBLINGUAL IMMUNOTHERAPY IN PATIENTS WITH GRASS POLLEN-INDUCED ALLERGIC RHINOCONJUNCTIVITIS
Author(s) -
И В Данилычева,
N I Ilina,
A E Shulzhenko
Publication year - 2013
Publication title -
rossijskij allergologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2686-682X
pISSN - 1810-8830
DOI - 10.36691/rja638
Subject(s) - sublingual immunotherapy , slit , medicine , sublingual administration , pollen , immunotherapy , immunology , dermatology , allergy , allergen , pharmacology , immune system , botany , biology , genetics
The article presents the results of a prospective noncomparative study of use of carbamylated monomeric allergoid Lais® for sublingual immunotherapy (SLIT) in patients with allergic rhinoconjunctivitis caused by pollen grasses. We suggest that SLIT with Lais® sublingual tablets is an effective and welltolerated form of treatment.